NSSK, a Japanese middle-market private equity firm, agreed to acquire Sakura Pharmacy Group, a chain of pharmacies, for $800m. Building on the business foundation that the Sakura Pharmacy Group has established, NSSK aims to provide support through its NSSK Value-up Program, its business expertise, and domestic and international networks, working with the current management team so that the Company Group can achieve more robust growth in its next stage of development. NSSK will seek to support new store openings with an eye to further sales growth and strengthening operations that provide greater added-value to society, which in turn is expected to lead to increased sales at existing stores.